Medicinal Products

Eylea

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Eylea
Active Substance aflibercept
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code S01LA05
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Eylea QR kod za zdravstvene radnike
Vodič za liječnike, verzija 8
Educational materials
for patients / caregivers
Eylea QR kod za bolesnike
Vaš vodič za lijek EYLEA otopina za injekciju, verzija 3

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o povećanom riziku od povišenog intraokularnog tlaka za lijek Eylea 40 mg/ml otopina za intravitrealnu injekciju u napunjenoj štrcaljki (aflibercept) 15.04.2021 Bayer d.o.o.
Back